Catheter Precision Inc (VTAK)
Catheter Precision, Inc. is a healthcare company focused on medical technologies for cardiac electrophysiology in the United States. Its product portfolio includes View into Ventricular Onset System, a non-invasive imaging platform that provides 3D cardiac mapping to help identify the origin sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts before electrophysiology procedures. The company also markets LockeT, a suture retention device used to temporarily secure sutures and assist clinicians with locating and removing them. Formerly known as Catheter Robotics Inc., Catheter Precision was founded in 2007 and is based in Fort Mill, South Carolina. The company’s common stock is listed on the NYSE under the symbol VTAK.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-VTAK
|
$0.19
|
26.7% Upside
|
Undervalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 12, 2026
|
0.1x
|
1.1x
|
2.182 M
|
13.529 M
|
88.7%
|
82.2%
|
-92.5
|
68.8%
|
